CONVERTIBLE DEBENTURES (Tables)

3 Months Ended

Jul. 31, 2018

CONVERTIBLE DEBENTURES [Abstract]

Convertible Notes Payable

The following table summarizes convertible notes payable as of July 31, 2018 and December 31, 2017:

			Bioanomaly, Inc.
			as of
	July 31, 2018		December 31, 2017
Convertible note payable - 1 holder, principal and interest due and payable 24 months from investment, monthly payments of interest - 5.0% per annum. Convertible into common stock, 20% discount to price target along with valuation cap set at $11 million (total market capitalization)	$	-	$	40,000
Convertible note payable - 1 holder, principal and interest due and payable 24 months from investment, monthly payments of interest - 5.0% per annum. Convertible into common stock, 20% discount to price target along with valuation cap set at $8 million (total market capitalization)		-		350,000
Convertible note payable - 1 holder, principal and interest due and payable 24 months from investment, monthly payments of interest - 5.0% per annum. Convertible into common stock, 20% discount to price target along with valuation cap set at $3 million (total market capitalization)		-		45,000
Convertible note payable - 1 holder, principal and interest due and payable 24 months from investment, monthly payments of interest - 5.0% per annum. Convertible into common stock, 20% discount to price target along with valuation cap set at $6 million (total market capitalization)		-		350,000
Total convertible notes payable		-		785,000
Less current maturities		-		(785,000	)
Long term portion of convertible notes payable	$	-	$	-